CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project focuses on developing modified cytokines to enhance their therapeutic potential in treating cancer and inflammation. By improving stability, specificity, and reducing toxicity, the new protein design strategy aims to create safer and more effective treatments for various immune-related conditions.
Cytokines are biomolecules of great potential interest for human therapy.
They modulate the immune system and play an important role in cancer, inflammation, immune response and tissue regeneration.
Despite their great potential, there are only a handful of cytokines approved for therapeutic purposes.
This is because many of them can have adverse side effects as they usually target different cell types, which adds to their low serum half-life, high production costs, or lack of physiological eff…
FUNDACIO CENTRE DE REGULACIO GENOMICA
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
